![Boston_H_color[33632]_edited.png](https://static.wixstatic.com/media/e60c5c_0b72738a80554196840094a8e387c5ed~mv2.png/v1/fill/w_338,h_77,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Boston_H_color%5B33632%5D_edited.png)
Immune-Related Adverse Events with Cancer Immunology
Tue, Nov 19
|Cinquecento Roman Trattoria
Case-Based Challenges for the Oncology Nurse Early identification of irAEs and initiation of systemic immunosuppression can improve outcomes without compromising the efficacy of immune checkpoint inhibition.
Time & Location
Nov 19, 2019, 5:30 PM – 8:00 PM
Cinquecento Roman Trattoria, 500 Harrison Ave, Boston, MA 02118, USA
Guests
About The Event
Tuesday, November 19, 2019 5:30 PM Registration/6:00 PM Presentation Cinquecento Roman Trattoria 500 Harrison Ave Boston, MA 02118
Activity Overview
Early identification of irAEs and initiation of systemic immunosuppression can improve outcomes without compromising the efficacy of immune checkpoint inhibition. As front-line caregivers, oncology nurses are optimally positioned to quickly identify such adverse events and employ appropropriate management strategies. The objective of this educational initiative is to provide oncology nurses and nurse practitioners attending Oncology Nursing Society’s (ONS) regional chapter meetings with evidence-based information on the latest developments in the use of cancer immunotherapy and effective management of irAEs.
Agenda
5 min Welcome and Introductions/Pre-activity Assessment 50 min A Whole New World: The Evolving Role of Checkpoint Inhibitors in Cancer Therapy
Immune-Related Adverse Events: Key Considerations for the Oncology Nurse
Case-based Challenges in irAE Management 5 min Faculty/Audience Q&A/Post-test
RSVP via the following link: https://www.ceconcepts.com/live/716Â
Learning Objectives
• Assess the clinical efficacy, unique response patterns, and safety profiles associated with checkpoint inhibitors in various types of cancers. • Evaluate the signs and symptoms of immune-related adverse events (irAEs) associated with checkpoint inhibitors and understand how to differentiate
these from other etiologies. • Review recent ASCO/NCCN guidelines for the management of irAEs and apply these recommendations to optimize patient care. • Using a case-based approach, discuss strategies oncology nurses can employ to overcome real-world challenges to the early recognition and
appropriate management of irAEs.
Presenter
Victoria Sherry, DNP, CRNP, ANP-BC, AOCNP Adult Oncology Nurse Practitioner for Thoracic Malignancies Abramson Cancer Center, University of Pennsylvania Medical Center Advanced Senior Lecturer, University of Pennsylvania School of Nursing Philadelphia, Pennsylvania
Accreditation
Nursing (ANCC)
In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity is designated for 1.0 contact hour.
Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.
Upon completion of a CNE request form, statements of credit for nurses will be issued within 30 business days.